Nipro Corporation (TYO:8086)

Market Cap	280.69B +35.8%
Revenue (ttm)	660.54B +2.5%
Net Income	13.50B +164.1%
EPS	73.36 +164.1%
Shares Out	163.10M
PE Ratio	23.46
Forward PE	21.84
Dividend	28.00 (1.63%)
Ex-Dividend Date	Mar 30, 2026

Volume	1,029,700
Open	1,705.50
Previous Close	1,707.50
Day's Range	1,697.50 - 1,726.50
52-Week Range	1,230.50 - 1,738.00
Beta	-0.03
Analysts	Hold
Price Target	1,708.00 (-0.76%)
Earnings Date	May 12, 2026

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical-Related business develops, manufactures, and sells injection and infusion products, artificial organ-related products, functional products, dialysis products, cell cultures, hospital products, diabetic products, and pharmaceuticals comprising generic and kit products; and manufactures medical equipment, including dialysis medical device products; and operates dialysis and training centers. The company’...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1947
• Employees: 39,168
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 8086

Financial Performance

In fiscal year 2026, Nipro's revenue was 660.54 billion, an increase of 2.47% compared to the previous year's 644.59 billion. Earnings were 13.50 billion, an increase of 164.11%.